Evotec Se Adr Stock Net Asset
| EVO Stock | USD 5.27 0.10 1.86% |
Evotec SE ADR fundamentals help investors to digest information that contributes to Evotec SE's financial success or failures. It also enables traders to predict the movement of Evotec Stock. The fundamental analysis module provides a way to measure Evotec SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evotec SE stock.
Evotec | Net Asset |
Evotec SE ADR Company Net Asset Analysis
Evotec SE's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Evotec SE Net Asset | 2.3 B |
Most of Evotec SE's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evotec SE ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Evotec Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Evotec SE is extremely important. It helps to project a fair market value of Evotec Stock properly, considering its historical fundamentals such as Net Asset. Since Evotec SE's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Evotec SE's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Evotec SE's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Evotec Total Assets
Total Assets |
|
Based on the recorded statements, Evotec SE ADR has a Net Asset of 2.3 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Evotec Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evotec SE's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evotec SE could also be used in its relative valuation, which is a method of valuing Evotec SE by comparing valuation metrics of similar companies.Evotec SE is currently under evaluation in net asset category among related companies.
Evotec SE Current Valuation Drivers
We derive many important indicators used in calculating different scores of Evotec SE from analyzing Evotec SE's financial statements. These drivers represent accounts that assess Evotec SE's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Evotec SE's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7B | 2.3B | 3.5B | 1.3B | 1.9B | 2.0B | |
| Enterprise Value | 1.9B | 2.4B | 3.3B | 1.4B | 2.0B | 2.1B |
Evotec SE Institutional Holders
Institutional Holdings refers to the ownership stake in Evotec SE that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Evotec SE's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Evotec SE's value.| Shares | Bank Of America Corp | 2023-12-31 | 5.7 K | Fmr Inc | 2023-12-31 | 3 K | Ubs Group Ag | 2023-12-31 | 2.3 K | Quadrant Capital Group Llc | 2023-12-31 | 2.1 K | U.s. Bancorp | 2023-12-31 | 1.2 K | Signaturefd, Llc | 2023-12-31 | 994 | Hhm Wealth Advisors, Llc | 2023-12-31 | 450 | Gamma Investing Llc | 2023-12-31 | 285 | First Manhattan Co. Llc | 2023-12-31 | 225 | Mubadala Investment Company Pjsc | 2023-12-31 | 4.6 M | Federated Hermes Inc | 2023-12-31 | 576.9 K |
Evotec Fundamentals
| Return On Equity | -0.0727 | ||||
| Return On Asset | 3.0E-4 | ||||
| Profit Margin | (0.11) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 954.54 M | ||||
| Shares Outstanding | 354.37 M | ||||
| Shares Owned By Institutions | 1.55 % | ||||
| Number Of Shares Shorted | 59.21 K | ||||
| Price To Earning | 444.00 X | ||||
| Price To Book | 2.12 X | ||||
| Price To Sales | 3.17 X | ||||
| Revenue | 781.43 M | ||||
| Gross Profit | 151.54 M | ||||
| EBITDA | (7.16 M) | ||||
| Net Income | (83.91 M) | ||||
| Cash And Equivalents | 823.67 M | ||||
| Cash Per Share | 2.33 X | ||||
| Total Debt | 626.2 M | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 6.33 X | ||||
| Cash Flow From Operations | 33.95 M | ||||
| Short Ratio | 1.41 X | ||||
| Earnings Per Share | (0.25) X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 12.8 | ||||
| Number Of Employees | 5.06 K | ||||
| Beta | 1.11 | ||||
| Market Capitalization | 1.87 B | ||||
| Total Asset | 2.3 B | ||||
| Retained Earnings | (476.29 M) | ||||
| Working Capital | 735.97 M | ||||
| Five Year Return | 4.88 % | ||||
| Net Asset | 2.3 B |
About Evotec SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evotec SE ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evotec SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evotec SE ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Evotec SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.Moving together with Evotec Stock
| 0.69 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
Moving against Evotec Stock
| 0.63 | PAHC | Phibro Animal Health Earnings Call This Week | PairCorr |
| 0.42 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE ADR to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Evotec SE Piotroski F Score and Evotec SE Altman Z Score analysis. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Evotec Stock analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.25) | Revenue Per Share 2.2085 | Quarterly Revenue Growth (0.16) | Return On Assets 0.0003 | Return On Equity (0.07) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.